Abstract
Cell immobilization is upgraded from a status of fundamental technique to an advanced approach for therapeutic applications. Thinking beyond the conventional surgical, radiation and chemotherapy for cancer management, the advent of immunotherapy via transplanting tumor antigens or engineered cancer cells has a promising role. Highlighting the significance of transplanting cellular vaccines and genetically engineered cells, creating a dynamic barrier through immobilization technique appreciates the physical isolation of cells from the systemic factors, continuous delivery of therapeutic molecules and formation of a local immune stimulatory environment. Transplantation of potential stem cells encapsulated in suitable matrices is also explored for cancer therapy. Irrespective of the therapeutic applications, cell immobilization approaches have prospects in generating reconstructive tumor models for cancer drug screening. In this chapter, the methods of cell immobilization, potential matrices for cell encapsulation, relevance in advanced cancer immunotherapy, and applications in reconstructive tumor models are discussed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- Ca:
-
Calcium
- PVA:
-
Polyvinyl alcohol
- IgG:
-
Immunoglobulin G
- PSS:
-
Polystyrene sulfonic acid
- PEI:
-
Polyethylene imine
- PEG:
-
Polyethylene glycol
- PVA:
-
Polyvinyl alcohol
- PLGA:
-
Polylactic-co-glycolic acid
- DNA:
-
Deoxyribonucleic acid
- mAbs:
-
Monoclonal antibodies
- FDA:
-
Food and drug administration
- PD-1:
-
Programmed death 1
- PDL-1:
-
Programmed death ligand 1
- CTLA:
-
Cytotoxic t‑lymphocyte antigen
- HBV:
-
Hepatitis B virus
- HPV:
-
Human papillomavirus
- RNA:
-
Ribonucleic acid
- APC:
-
Atigen-presenting cells
- DC:
-
Dendritic cell
- GM-CSF:
-
Granulocyte-macrophage colony-stimulating factor
- IL-2:
-
Interleukin 2
- PAP:
-
Prostatic acid phosphates
- MART-1:
-
Melanoma associated antigen recognized by T cells
- EVA:
-
Ethyl vinyl acetate
- MIP:
-
Macrophage inflammatory protein
- CD:
-
Cluster of differentiation
- HER:
-
Human epidermal growth factor receptor
- MSR:
-
Mesoporous silica rods
- OVA:
-
Ovalbumin
- ECM:
-
Extracellular matrix
- TME:
-
Tumor microenvironment
- CNC:
-
Cellulose nanocrystals
References
Achilli T-M, Meyer J, Morgan JR (2012) Advances in the formation, use and understanding of multi-cellular spheroids. Expert Opin Biol Ther 12:1347–1360. https://doi.org/10.1517/14712598.2012.707181
Aggarwal BB, Danda D, Gupta S, Gehlot P (2009) Models for prevention and treatment of cancer: problems vs promises. Biochem Pharmacol 78:1083–1094. https://doi.org/10.1016/j.bcp.2009.05.027
Albuquerque K, Giangreco D, Morrison C et al (2011) Radiation-related predictors of hematologic toxicity after concurrent chemoradiation for cervical cancer and implications for bone marrow-sparing pelvic IMRT. Int J Radiat Oncol Biol Phys 79:1043–1047. https://doi.org/10.1016/j.ijrobp.2009.12.025
Alemany-Ribes M, Semino CE (2014) Bioengineering 3D environments for cancer models. Adv Drug Deliv Rev 79–80:40–49. https://doi.org/10.1016/j.addr.2014.06.004
Alessandri K, Sarangi BR, Gurchenkov VV et al (2013) Cellular capsules as a tool for multicellular spheroid production and for investigating the mechanics of tumor progression in vitro. Proc Natl Acad Sci USA 110:14843–14848. https://doi.org/10.1073/pnas.1309482110
Ali OA, Huebsch N, Cao L et al (2009) Infection-mimicking materials to program dendritic cells in situ. Nat Mater 8:151–158. https://doi.org/10.1038/nmat2357
Ali OA, Verbeke C, Johnson C et al (2014) Identification of immune factors regulating antitumor immunity using polymeric vaccines with multiple adjuvants. Cancer Res 74:1670–1681. https://doi.org/10.1158/0008-5472.CAN-13-0777
Al-Mefty O, Kersh JE, Routh A, Smith RR (1990) The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 73:502–512. https://doi.org/10.3171/jns.1990.73.4.0502
Asada H, Kishida T, Hirai H et al (2002) Significant antitumor effects obtained by autologous tumor cell vaccine engineered to secrete interleukin (IL)-12 and IL-18 by means of the EBV/lipoplex. Mol Ther 5:609–616. https://doi.org/10.1006/mthe.2002.0587
Bahulekar R, Ayyangar NR, Ponrathnam S (1991) Polyethyleneimine in immobilization of biocatalysts. Enzyme and Microbial Technology 13:858–868. https://doi.org/10.1016/0141-0229(91)90101-F
Bal SM, Hortensius S, Ding Z et al (2011) Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination. Vaccine 29:1045–1052. https://doi.org/10.1016/j.vaccine.2010.11.061
Bartlett R, Everett W, Lim S et al (2014) Personalized In Vitro Cancer Modeling—Fantasy or Reality? Transl Oncol 7:657–664. https://doi.org/10.1016/j.tranon.2014.10.006
Baruch L, Machluf M (2006) Alginate-chitosan complex coacervation for cell encapsulation: effect on mechanical properties and on long-term viability. Biopolymers 82:570–579. https://doi.org/10.1002/bip.20509
Bencherif S, Draganov D, Lewin S et al (2013) Immunologically active cryogels for breast cancer therapy (P4329). J Immunol 190: 126.1
Bencherif SA, Sands RW, Bhatta D et al (2012) Injectable preformed scaffolds with shape-memory properties. Proc Natl Acad Sci USA 109:19590–19595. https://doi.org/10.1073/pnas.1211516109
Bencherif SA, Warren Sands R, Ali OA et al (2015) Injectable cryogel-based whole-cell cancer vaccines. Nat Commun 6:7556. https://doi.org/10.1038/ncomms8556
Benton G, Arnaoutova I, George J et al (2014) Matrigel: from discovery and ECM mimicry to assays and models for cancer research. Adv Drug Deliv Rev 79–80:3–18. https://doi.org/10.1016/j.addr.2014.06.005
Bertrand A, Kostine M, Barnetche T et al (2015) Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis. BMC Med 13:211. https://doi.org/10.1186/s12916-015-0455-8
Borin GP, de Melo RR, Crespim E et al (2018) An overview on polymer gels applied to enzyme and cell immobilization. In: Thakur VK, Thakur MK (eds) Polymer gels: science and fundamentals. Springer, Singapore, pp 63–86
Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424. https://doi.org/10.3322/caac.21492
Calmeiro J, Carrascal M, Gomes C et al (2019) Biomaterial-based platforms for in situ dendritic cell programming and their use in antitumor immunotherapy. J Immunother Cancer 7. https://doi.org/10.1186/s40425-019-0716-8
Chau M, Sriskandha SE, Thérien-Aubin H, Kumacheva E (2015) Supramolecular nanofibrillar polymer hydrogels. In: Seiffert S (ed) Supramolecular polymer networks and gels. Springer International Publishing, Cham, pp 167–208
Chaudhuri O, Koshy ST, Branco da Cunha C et al (2014) Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium. Nat Mater 13:970–978. https://doi.org/10.1038/nmat4009
Chiavenna SM, Jaworski JP, Vendrell A (2017) State of the art in anti-cancer mAbs. J Biomed Sci 24:15. https://doi.org/10.1186/s12929-016-0311-y
Cruz LJ, Rueda F, Simón L et al (2014) Liposomes containing NY-ESO-1/tetanus toxoid and adjuvant peptides targeted to human dendritic cells via the Fc receptor for cancer vaccines. Nanomedicine (Lond) 9:435–449. https://doi.org/10.2217/NNM.13.66
Cui X, Hartanto Y, Zhang H (2017) Advances in multicellular spheroids formation. J R Soc Interface. https://doi.org/10.1098/rsif.2016.0877
DeFrancesco L (2019) Provenge twists again. In: Nature Biotechnology. https://www.nature.com/articles/nbt0910-882a. Accessed 14 Sep
Dendreon Bankrupt (2014) Nature Biotechnology 32: 1176. https://doi.org/10.1038/nbt1214-1176a
Elakkiya M, Prabhakaran D, Thirumarimurugan M (2016) Methods of cell immobilization and its applications. Methods 5(4):211–216
Fischbach C, Kong HJ, Hsiong SX et al (2009) Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement. Proc Natl Acad Sci USA 106:399–404. https://doi.org/10.1073/pnas.0808932106
Fishman M, Hunter TB, Soliman H et al (2008) Phase II trial of B7–1 (CD-86) transduced, cultured autologous tumor cell vaccine plus subcutaneous interleukin-2 for treatment of stage IV renal cell carcinoma. J Immunother 31:72–80. https://doi.org/10.1097/CJI.0b013e31815ba792
Gill BJ, Gibbons DL, Roudsari LC et al (2012) A synthetic matrix with independently tunable biochemistry and mechanical properties to study epithelial morphogenesis and EMT in a lung adenocarcinoma model. Cancer Res 72:6013–6023. https://doi.org/10.1158/0008-5472.CAN-12-0895
Gu L, Mooney DJ (2016) Biomaterials and emerging anticancer therapeutics: engineering the microenvironment. Nat Rev Cancer 16:56–66. https://doi.org/10.1038/nrc.2015.3
Guo C, Manjili MH, Subjeck JR et al (2013) Therapeutic cancer vaccines: past, present and future. Adv Cancer Res 119:421–475. https://doi.org/10.1016/B978-0-12-407190-2.00007-1
Gupta M, Davis M, LeGrand S et al (2013) Nausea and vomiting in advanced cancer: the Cleveland clinic protocol. J Support Oncol 11:8–13. https://doi.org/10.1016/j.suponc.2012.10.002
Gurski LA, Jha AK, Zhang C et al (2009) Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials 30:6076–6085. https://doi.org/10.1016/j.biomaterials.2009.07.054
Helmlinger G, Netti PA, Lichtenbeld HC et al (1997) Solid stress inhibits the growth of multicellular tumor spheroids. Nat Biotechnol 15:778–783. https://doi.org/10.1038/nbt0897-778
Hollingsworth RE, Jansen K (2019) Turning the corner on therapeutic cancer vaccines. NPJ Vaccines 4: 1–10. https://doi.org/10.1038/s41541-019-0103-y
Hu S, de Vos P (2019) Polymeric approaches to reduce tissue responses against devices applied for islet-cell encapsulation. Front Bioeng Biotechnol 7:134. https://doi.org/10.3389/fbioe.2019.00134
Ichihashi T, Satoh T, Sugimoto C, Kajino K (2013) Emulsified phosphatidylserine, simple and effective peptide carrier for induction of potent epitope-specific T cell responses. PLoS ONE 8:e60068. https://doi.org/10.1371/journal.pone.0060068
Immune Checkpoint Blockade Therapy: Merits and Demerits. In: ResearchGate. https://www.researchgate.net/publication/309267727_Immune_Checkpoint_Blockade_Therapy_Merits_and_Demerits. Accessed 14 Mar 2019
Joung JJ, Akin C, Royer GP (1987) Immobilization of growing cells by polyethyleneimine-modified alginate. Appl Biochem Biotechnol 14:259–275. https://doi.org/10.1007/BF02800313
Katt ME, Placone AL, Wong AD et al (2016) In vitro tumor models: advantages, disadvantages, variables, and selecting the right platform. Front Bioeng Biotechnol 4. https://doi.org/10.3389/fbioe.2016.00012
Keenan BP, Jaffee EM (2012) Whole cell vaccines–past progress and future strategies. Semin Oncol 39:276–286. https://doi.org/10.1053/j.seminoncol.2012.02.007
Kim J, Li WA, Choi Y et al (2015) Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy. Nat Biotechnol 33:64–72. https://doi.org/10.1038/nbt.3071
Knobeloch T, Abadi SEM, Bruns J et al (2017) Injectable polyethylene glycol hydrogel for islet encapsulation: an in vitro and in vivo characterization. Biomed Phys Eng Express 3. https://doi.org/10.1088/2057-1976/aa742b
Koh W-G, Revzin A, Pishko MV (2002) Poly(ethylene glycol) hydrogel microstructures encapsulating living cells. Langmuir 18:2459–2462
Kondo J, Endo H, Okuyama H et al (2011) Retaining cell-cell contact enables preparation and culture of spheroids composed of pure primary cancer cells from colorectal cancer. Proc Natl Acad Sci USA 108:6235–6240. https://doi.org/10.1073/pnas.1015938108
Kuai R, Ochyl LJ, Bahjat KS et al (2017) Designer vaccine nanodiscs for personalized cancer immunotherapy. Nat Mater 16:489–496. https://doi.org/10.1038/nmat4822
Kumamoto T, Huang EK, Paek HJ et al (2002) Induction of tumor-specific protective immunity by in situ Langerhans cell vaccine. Nat Biotechnol 20:64–69. https://doi.org/10.1038/nbt0102-64
Kumar A, Tripathi A (2012) Biopolymeric scaffolds for Tissue Engineering. In: Tiwari A, Srivastava RB (Ed) Biotechnology in Biopolymers Developments, Applications and Challenging Areas, i-Smithers Repra Publication Ltd. United Kingdom, p 233–285
Lang SH, Sharrard RM, Stark M et al (2001) Prostate epithelial cell lines form spheroids with evidence of glandular differentiation in three-dimensional Matrigel cultures. Br J Cancer 85:590–599. https://doi.org/10.1054/bjoc.2001.1967
Lazzari G, Couvreur P, Mura S (2017) Multicellular tumor spheroids: a relevant 3D model for the in vitro preclinical investigation of polymer nanomedicines. Polym Chem 8:4947–4969. https://doi.org/10.1039/C7PY00559H
Lee GY, Kenny PA, Lee EH, Bissell MJ (2007) Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods 4:359–365. https://doi.org/10.1038/nmeth1015
Li Y, Khuu N, Gevorkian A et al (2017) Supramolecular nanofibrillar thermoreversible hydrogel for growth and release of cancer spheroids. Angew Chem Int Ed 56:6083–6087. https://doi.org/10.1002/anie.201610353
Li Y, Kumacheva E (2018) Hydrogel microenvironments for cancer spheroid growth and drug screening. Sci Adv 4: eaas8998. https://doi.org/10.1126/sciadv.aas8998
Liang Y, Jeong J, DeVolder RJ et al (2011) A cell-instructive hydrogel to regulate malignancy of 3D tumor spheroids with matrix rigidity. Biomaterials 32:9308–9315. https://doi.org/10.1016/j.biomaterials.2011.08.045
Liu J, Tan Y, Zhang H et al (2012) Soft fibrin gels promote selection and growth of tumorigenic cells. Nature Mater 11:734–741. https://doi.org/10.1038/nmat3361
Liu Y, Xiao L, Joo K-I et al (2014) In situ modulation of dendritic cells by injectable thermosensitive hydrogels for cancer vaccines in mice. Biomacromol 15:3836–3845. https://doi.org/10.1021/bm501166j
Loessner D, Stok KS, Lutolf MP et al (2010) Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. Biomaterials 31:8494–8506. https://doi.org/10.1016/j.biomaterials.2010.07.064
Longo DL (2010) New therapies for castration-resistant prostate cancer. N Engl J Med 363:479–481. https://doi.org/10.1056/NEJMe1006300
Lutolf MP, Hubbell JA (2005) Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23:47–55. https://doi.org/10.1038/nbt1055
Maltaris T, Seufert R, Fischl F et al (2007) The effect of cancer treatment on female fertility and strategies for preserving fertility. Eur J Obstet Gynecol Reprod Biol 130:148–155. https://doi.org/10.1016/j.ejogrb.2006.08.006
Melvik JE, Dornish M (2004) Alginate as a carrier for cell immobilisation. In: Nedović V, Willaert R (eds) Fundamentals of cell immobilisation biotechnology. Springer, Netherlands, Dordrecht, pp 33–51
Mittal D, Gubin MM, Schreiber RD, Smyth MJ (2014) New insights into cancer immunoediting and its three component phases–elimination, equilibrium and escape. Curr Opin Immunol 27:16–25. https://doi.org/10.1016/j.coi.2014.01.004
Mooney DJ, Baldwin DF, Suh NP et al (1996) Novel approach to fabricate porous sponges of poly(d, l-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials 17:1417–1422. https://doi.org/10.1016/0142-9612(96)87284-X
Munhoz RR, Postow MA (2016) Recent advances in understanding antitumor immunity. F1000Res 5:2545. https://doi.org/10.12688/f1000research.9356.1
Nemunaitis J (2005) Vaccines in cancer: GVAX, a GM-CSF gene vaccine. Expert Rev Vaccines 4:259–274. https://doi.org/10.1586/14760584.4.3.259
Nunes AS, Barros AS, Costa EC et al (2019) 3D tumor spheroids as in vitro models to mimic in vivo human solid tumors resistance to therapeutic drugs. Biotechnol Bioeng 116:206–226. https://doi.org/10.1002/bit.26845
Nuttelman CR, Rice MA, Rydholm AE et al (2008) Macromolecular monomers for the synthesis of hydrogel niches and their application in cell encapsulation and tissue engineering. Prog Polym Sci 33:167–179. https://doi.org/10.1016/j.progpolymsci.2007.09.006
Pampaloni F, Reynaud EG, Stelzer EHK (2007) The third dimension bridges the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8:839–845. https://doi.org/10.1038/nrm2236
Pedron S, Becka E, Harley BAC (2013) Regulation of glioma cell phenotype in 3D matrices by hyaluronic acid. Biomaterials 34:7408–7417. https://doi.org/10.1016/j.biomaterials.2013.06.024
Reátegui E, Kasinkas L, Kniesz K et al (2014) Silica–PEG gel immobilization of mammalian cells. J Mater Chem B 2:7440–7448. https://doi.org/10.1039/C4TB00812J
Remacle C (2019) The patients’ journey with targeted therapies. In: Charnay-Sonnek F, Murphy AE (eds) Principle of nursing in oncology: new challenges. Springer International Publishing, Cham, pp 65–82
Risbud MV, Bhargava S, Bhonde RR (2003) In vivo biocompatibility evaluation of cellulose macrocapsules for islet immunoisolation: Implications of low molecular weight cut-off. J Biomed Mater Res a 66:86–92. https://doi.org/10.1002/jbm.a.10522
Risbud MV, Bhonde RR (2001) Suitability of cellulose molecular dialysis membrane for bioartificial pancreas: in vitro biocompatibility studies. J Biomed Mater Res 54:436–444. https://doi.org/10.1002/1097-4636(20010305)54:3%3c436::aid-jbm180%3e3.0.co;2-8
Ruel-Gariépy E, Leclair G, Hildgen P et al (2002) Thermosensitive chitosan-based hydrogel containing liposomes for the delivery of hydrophilic molecules. J Control Release 82:373–383. https://doi.org/10.1016/S0168-3659(02)00146-3
Salter GJ, Kell DB (1991) New materials and technology for cell immobilization. Curr Opin Biotechnol 2:385–389. https://doi.org/10.1016/S0958-1669(05)80143-0
Sato T, Stange DE, Ferrante M et al (2011) Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett’s epithelium. Gastroenterology 141:1762–1772. https://doi.org/10.1053/j.gastro.2011.07.050
Schmidt-Winkel P, Yang P, Margolese DI et al (1999) Fluoride-induced hierarchical ordering of mesoporous silica in aqueous acid-syntheses. Adv Mater 11:303–307. https://doi.org/10.1002/(SICI)1521-4095(199903)11:4%3c303::AID-ADMA303%3e3.0.CO;2-M
Schwendener RA (2014) Liposomes as vaccine delivery systems: a review of the recent advances. Therapeutic Adv Vaccines 2:159–182. https://doi.org/10.1177/2051013614541440
Shin S, Ikram M, Subhan F et al (2016) Alginate–marine collagen–agarose composite hydrogels as matrices for biomimetic 3D cell spheroid formation. RSC Adv 6:46952–46965. https://doi.org/10.1039/C6RA01937D
Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30. https://doi.org/10.3322/caac.21442
Smidsrød O, Skja G, (1990) Alginate as immobilization matrix for cells. Trends Biotechnol 8:71–78. https://doi.org/10.1016/0167-7799(90)90139-O
Sobol M, Bartkowiak A, de Haan B, de Vos P (2013) Cytotoxicity study of novel water-soluble chitosan derivatives applied as membrane material of alginate microcapsules. J Biomed Mater Res A 101:1907–1914. https://doi.org/10.1002/jbm.a.34500
Speiser DE, Flatz L (2014) Cancer immunotherapy drives implementation science in oncology. Hum Vaccin Immunother 10:3107–3110. https://doi.org/10.4161/21645515.2014.983000
Suarez-Arnedo A, Sarmiento P, Cruz JC et al (2018) 3D alginate hydrogels with controlled mechanical properties for mammalian cell encapsulation. IX Int Seminar Biomed Eng (SIB) 2018:1–5. https://doi.org/10.1109/sib.2018.8467745
Suarez-Arnedo A, Narváez DM, Sarmiento P et al (2019) Tridimensional alginate disks of tunable topologies for mammalian cell encapsulation. Anal Biochem 574:31–33. https://doi.org/10.1016/j.ab.2019.03.008
Sun Z, Liang J, Dong X et al (2018) Injectable hydrogels coencapsulating granulocyte-macrophage colony-stimulating factor and ovalbumin nanoparticles to enhance antigen uptake efficiency. ACS Appl Mater Interfaces 10:20315–20325. https://doi.org/10.1021/acsami.8b04312
Szot CS, Buchanan CF, Freeman JW, Rylander MN (2011) 3D in vitro bioengineered tumors based on collagen I hydrogels. Biomaterials 32:7905–7912. https://doi.org/10.1016/j.biomaterials.2011.07.001
Tripathi A, Kathuria N, Kumar A (2009) Elastic and macroporous agarose-gelatin cryogels with isotropic and anisotropic porosity for tissue engineering. J Biomed Mater Res A 90(3):680–694. https://doi.org/10.1002/jbm.a.32127
Tripathi A, Kumar A (2011) Multi-featured macroporous agarose-alginate cryogel: synthesis and characterization for bioengineering applications. Macromol Biosci 11(1):22–35
Tripathi A, Melo JS (2015) Preparation of sponge-like biocomposite agarose-chitosan scaffold with primary hepatocytes for establishing an in-vitro 3D liver tissue model. RSC Adv 5:30701–30710
Tripathi A, Melo JS (2016) Synthesis of low-density biopolymeric chitosan-agarose cryomatrix and its surface functionalization with bio-transformed melanin for the enhanced recovery of uranium(VI) from aqueous subsurfaces. RSC Adv 6:37067–37078
Tripathi A (2019) Melo JS (2019) Cryostructurization of polymeric systems for developing macroporous cryogel as a foundational framework in bioengineering applications. J Chem Sci 131:92. https://doi.org/10.1007/s12039-019-1670-1
Tripathi A, Melo JS (eds) (2017) Advances in biomaterials for biomedical applications. Springer-Nature, Singapore
Tripathi A, Melo JS D’Souza SF (2013a) Magnetic nanoparticles in tissue regeneration. In: Tiwari A Tiwari A (eds) Nanomaterials in drug delivery, imaging, and tissue engineering. WILEY-Scrivener Publisher, USA, pp 443–492. ISBN 9781118290323
Tripathi A, Vishnoi T, Singh D, Kumar A (2013) Modulated crosslinking of macroporous polymeric cryogel affects in vitro cell adhesion and growth. Macromol Biosci 13(7):838–850. https://doi.org/10.1002/mabi.201200398
Tubiana M (1971) The kinetics of tumour cell proliferation and radiotherapy. Br J Radiol 44:325–347. https://doi.org/10.1259/0007-1285-44-521-325
van Willigen WW, Bloemendal M, Gerritsen WR et al (2018) Dendritic cell cancer therapy: vaccinating the right patient at the right time. Front Immunol 9. https://doi.org/10.3389/fimmu.2018.02265
Villalobos A (2006) Dealing with chemotherapy extravasations: a new technique. J Am Anim Hosp Assoc 42:321–325. https://doi.org/10.5326/0420321
Wang C, Tong X, Yang F (2014) Bioengineered 3D brain tumor model to elucidate the effects of matrix stiffness on glioblastoma cell behavior using PEG-based hydrogels. Mol Pharm 11:2115–2125. https://doi.org/10.1021/mp5000828
Wang P-F, Chen Y, Song S-Y et al (2017) Immune-related adverse events associated with anti-PD-1/PD-L1 treatment for malignancies: a meta-analysis. Front Pharmacol 8:730. https://doi.org/10.3389/fphar.2017.00730
Weaver VM, Petersen OW, Wang F et al (1997) Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137:231–245. https://doi.org/10.1083/jcb.137.1.231
Weber LM, Lopez CG, Anseth KS (2009) Effects of PEG hydrogel crosslinking density on protein diffusion and encapsulated islet survival and function. J Biomed Mater Res A 90:720–729. https://doi.org/10.1002/jbm.a.32134
Wei G, Ma W, Zhang A et al (2018) Enhancing catalytic stability and cadaverine tolerance by whole-cell immobilization and the addition of cell protectant during cadaverine production. Appl Microbiol Biotechnol 102:7837–7847. https://doi.org/10.1007/s00253-018-9190-3
Xu Y, Kim C-S, Saylor DM, Koo D (2017) Polymer degradation and drug delivery in PLGA-based drug-polymer applications: A review of experiments and theories. J Biomed Mater Res Part B Appl Biomater 105:1692–1716. https://doi.org/10.1002/jbm.b.33648
Yang HK, Ham D-S, Park H-S et al (2016) Long-term efficacy and biocompatibility of encapsulated islet transplantation with chitosan-coated alginate capsules in mice and canine models of diabetes. Transplantation 100:334–343. https://doi.org/10.1097/TP.0000000000000927
Yang K-C, Qi Z, Wu C-C et al (2010) The cytoprotection of chitosan based hydrogels in xenogeneic islet transplantation: an in vivo study in streptozotocin-induced diabetic mouse. Biochem Biophys Res Commun 393:818–823. https://doi.org/10.1016/j.bbrc.2010.02.089
Yang Z, Zhao X (2011) A 3D model of ovarian cancer cell lines on peptide nanofiber scaffold to explore the cell–scaffold interaction and chemotherapeutic resistance of anticancer drugs. Int J Nanomedicine 6:303–310. https://doi.org/10.2147/IJN.S15279
Yeung TM, Gandhi SC, Wilding JL et al (2010) Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci USA 107:3722–3727. https://doi.org/10.1073/pnas.0915135107
Zent R, Pozzi A (2010) Cell-extracellular matrix interactions in cancer. Springer-Verlag, New York
Zhang H, Chen J (2018) Current status and future directions of cancer immunotherapy. J Cancer 9:1773–1781. https://doi.org/10.7150/jca.24577
Zhang R, Billingsley MM, Mitchell MJ (2018) Biomaterials for vaccine-based cancer immunotherapy. J Control Release 292:256–276. https://doi.org/10.1016/j.jconrel.2018.10.008
Zucca P, Fernandez-Lafuente R, Sanjust E (2016) Agarose and its derivatives as supports for enzyme immobilization. Molecules 21. 10.3390/molecules21111577
Acknowledgements
Authors would like to acknowledge Board of Research in Nuclear Sciences, Department of Atomic Energy, Government of India for the financial support.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Komeri, R. et al. (2021). Prospects of Cell Immobilization in Cancer Research and Immunotherapy. In: Tripathi, A., Melo, J.S. (eds) Immobilization Strategies . Gels Horizons: From Science to Smart Materials. Springer, Singapore. https://doi.org/10.1007/978-981-15-7998-1_4
Download citation
DOI: https://doi.org/10.1007/978-981-15-7998-1_4
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-7997-4
Online ISBN: 978-981-15-7998-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)